REMS Provision Left Out of PDUFA, GPhA Criticizes Lack of House Access
Generic-drug makers are raising concerns with their access to House user fee bill discussions because unlike the Senate, House lawmakers didn’t hold a joint meeting with the FDA, PhRMA and GPhA on certain cost-saving provisions of its FDA user fee bill.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.